Clinical trial · Observational
The Treatment and Natural History of Acromegaly
Acromegaly Treatment and Natural History
NCT00001981CI-TRIAL-00048519completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate the treatment and natural history of acromegaly. We have a longstanding interest in acromegaly treatment, and a cohort that has been followed for 30 years, or more in some cases. We will continue to follow patients and recruit new patients for treatment and follow-up. Blood and pituitary tumor tissue (when available through clinical care) will be saved for future analyses related to acromegaly.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acromegaly | — | UNRESOLVED | — |
| Pituitary Neoplasm | Pituitary Gland Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Patients with acromegaly
- description
- Patients with acromegaly
Primary outcomes (1)
- measure
- resolution of IGF-1 Growth Hormone abnormality
- timeFrame
- every 6 months & at end of study
- description
- resolution of IGF-1 abnormality
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
* INCLUSION CRITERIA: Patients will be enrolled who are 18 years of age or over who are referred for care.
References
Publications (0)
Data not yet available
No reference posted for this study.